Electronic Prescribing Functions in Pharmacy Practice (Resolution 118-2-22)
RESOLUTION NO: 118-2-22TITLE: Electronic Prescribing Functions in Pharmacy PracticeACTION: PASS WHEREAS, at least 24 states have adopted or mandated e-prescribing as the use of e-prescribing continues to evolve; and WHEREAS, e-prescribing can help to reduce the number of fraudulent prescriptions for controlled substances, improve the accuracy of the prescribing and dispensing processes, enhance the efficiency of pharmacy […]
Read More ›National Standardized Pharmacy Jurisprudence Examination (Resolution 118-3-22)
RESOLUTION NO: 118-3-22TITLE: National Standardized Pharmacy Jurisprudence ExaminationACTION: PASS WHEREAS, not every state board of pharmacy requires pharmacist candidates to take the Multistate Pharmacy Jurisprudence Examination® (MPJE®) for licensure; and WHEREAS, MPJE item writing and review activities require significant board of pharmacy staff resources; and WHEREAS, many state-specific laws are similar, if not identical; and WHEREAS, pharmacists’ knowledge of federal […]
Read More ›National Standards for the Licensure of Wholesale Drug Distributors and Third-Party Logistics Providers (Resolution 118-4-22)
RESOLUTION NO: 118-4-22TITLE: National Standards for the Licensure of Wholesale Drug Distributors and Third-Party Logistics ProvidersACTION: PASS WHEREAS, the Drug Quality and Security Act (DQSA) was enacted by Congress on November 27, 2013; and WHEREAS, Title II of DQSA, the Drug Supply Chain Security Act, outlines that United States Food and Drug Administration (FDA) shall establish, by regulation, […]
Read More ›Ryan Haight Act and Drug Enforcement Administration Telepharmacy Regulations (Resolution 118-5-22)
RESOLUTION NO: 118-5-22TITLE: Ryan Haight Act and Drug Enforcement Administration Telepharmacy RegulationsACTION: PASS WHEREAS, the Ryan Haight Act, which was aimed at curbing the illegal online sale of controlled substances (CS), was passed by Congress in 2008 and defines “online pharmacy”;1and WHEREAS, the Ryan Haight Act does not have any reference to or provide any definition of […]
Read More ›Multistate Licensure (Resolution 118-6-22)
RESOLUTION NO: 118-6-22TITLE: Multistate LicensureACTION: PASS WHEREAS, other health professions have developed infrastructure for multistate compacts for license portability to increase access to care; and WHEREAS, NABP convened the Task Force on Mutual-Recognition Licensure and published its report in September 2018, which recommended examining enhancements to the current license transfer system that will address changes in practice […]
Read More ›Recognition Resolution (Resolution 118-7-22)
RESOLUTION NO: 118-7-22TITLE: Recognition ResolutionACTION: PASS WHEREAS, the individuals listed here have made significant contributions to NABP, the protection of public health, and the practice of pharmacy: Past Honorary President Carl W. Aron (LA)Past Honorary President Ray Joubert (SK)Past President Llyn Allan Lloyd (AZ, ID)Past Honorary President William Lee “Buck” Stevens (MS)Eric Alvarez (FL)Charles L. Appleby, […]
Read More ›Point-of-Care Testing and Treatment by Pharmacists (Resolution 119-1-23)
RESOLUTION NO: 119-1-23TITLE: Point-of-Care Testing and Treatment by PharmacistsACTION: PASS WHEREAS, pharmacists, as highly accessible health care providers, have played a vital role in the public health response to the coronavirus disease 2019 (COVID-19) pandemic; and WHEREAS, the COVID-19 pandemic and related emergency declarations allowed for an expanded scope of practice for pharmacists, allowing them to order […]
Read More ›Drug Supply Chain Security Act Education and Compliance Assessment (Resolution 119-2-23)
RESOLUTION NO: 119-2-23TITLE: Drug Supply Chain Security Act Education and Compliance AssessmentACTION: PASS WHEREAS, suspect products, as defined by Title II Drug Supply Chain Security Act (DSCSA) of the Drug Quality and Security Act (DQSA), pose a significant risk to patient safety; andWHEREAS, suspect products, as defined by Title II Drug Supply Chain Security Act (DSCSA) […]
Read More ›Increasing Access to Medications for Opioid Use Disorder (Resolution 119-3-23)
RESOLUTION NO: 119-3-23TITLE: Increasing Access to Medications for Opioid Use DisorderACTION: PASS WHEREAS, opioid use disorder (OUD) continues to grow to epidemic proportions in the United States, with an estimated 3 million people suffering from OUD in 2021;1 and WHEREAS, also in 2021, nearly 108,000 people died from drug overdoses, with approximately 81,000 of those deaths involving a […]
Read More ›Expanding Pharmacy Technician Seats on State Boards of Pharmacy (Resolution 119-4-23)
RESOLUTION NO: 119-4-23TITLE: Expanding Pharmacy Technician Seats on State Boards of PharmacyACTION: PASS WHEREAS, in 2007, the Wyoming State Board of Pharmacy was the first to add a pharmacy technician member to serve on the Board; and WHEREAS, since 2007, Arizona, Illinois, Iowa, Massachusetts, Michigan, Montana, North Dakota, Oregon, Rhode Island, Texas, Utah, Vermont, and Washington have […]
Read More ›